PLATINUM ANALOG COMBINATION CHEMOTHERAPY - CISPLATIN AND CARBOPLATIN - A PHASE-I TRIAL WITH PHARMACOKINETIC ASSESSMENT OF THE EFFECT OF CISPLATIN ADMINISTRATION ON CARBOPLATIN EXCRETION

被引：69
|
作者：
TRUMP, DL [1 ]
GREM, JL [1 ]
TUTSCH, KD [1 ]
WILLSON, JKV [1 ]
SIMON, KJ [1 ]
ALBERTI, D [1 ]
STORER, B [1 ]
TORMEY, DC [1 ]
机构：
[1] WILLIAM S MIDDLETON MEM VET ADM HOSP,MADISON,WI 53705
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1987年 / 5卷 / 08期
关键词：
D O I：
10.1200/JCO.1987.5.8.1281
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1281 / 1289
页数：9
相关论文
共 50 条
  • [41] Phase I/pharmacokinetic trial of the taxane analogue BMS-184476 in combination with carboplatin (CBDCA) or cisplatin (CDDP) administered as an IV infusion every 3 weeks.
    Stevenson, JP
    Gallagher, M
    Ryan, WF
    Vaughn, DJ
    Algazy, K
    Tortora, K
    Skillings, J
    O'Dwyer, PJ
    CLINICAL CANCER RESEARCH, 1999, 5 : 3797S - 3797S
  • [42] A phase I trial of sorafenib combined with cisplatin/etoposide or carboplatin/pemetrexed in refractory solid tumor patients
    Davies, Janine M.
    Dhruva, Nirav S.
    Walko, Christine M.
    Socinski, Mark A.
    Bernard, Stephen
    Hayes, D. Neil
    Kim, William Y.
    Ivanova, Anastasia
    Keller, Kimberly
    Hilbun, Layla R.
    Chiu, Michael
    Dees, E. Claire
    Stinchcombe, Thomas E.
    LUNG CANCER, 2011, 71 (02) : 151 - 155
  • [43] Tumor platinum concentration following intraperitoneal administration of cisplatin versus carboplatin in an ovarian cancer model
    Jandial, Danielle D.
    Messer, Karen
    Farshchi-Heydari, Salman
    Pu, Minya
    Howell, Stephen B.
    GYNECOLOGIC ONCOLOGY, 2009, 115 (03) : 362 - 366
  • [44] Accumulation, fractionation, and analysis of platinum in toxicologically affected tissues after cisplatin, oxaliplatin, and carboplatin administration
    Esteban-Fernandez, D.
    Verdaguer, J. M.
    Ramirez-Camacho, R.
    Palacios, M. A.
    Gomez-Gomez, M. M.
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2008, 32 (02) : 140 - 146
  • [45] PHASE-I CLINICAL AND PHARMACOLOGIC TRIAL OF CARBOPLATIN DAILY FOR 5 DAYS
    VANECHO, DA
    EGORIN, MJ
    WHITACRE, MY
    OLMAN, EA
    AISNER, J
    CANCER TREATMENT REPORTS, 1984, 68 (09): : 1103 - 1114
  • [46] COMPARISON OF PLATINUM CONCENTRATIONS IN HUMAN HEAD AND NECK TUMORS FOLLOWING ADMINISTRATION OF CARBOPLATIN, IPROPLATIN OR CISPLATIN
    HECQUET, B
    CATY, A
    FOURNIER, C
    LEFEBVRE, JL
    ADENIS, L
    BULLETIN DU CANCER, 1987, 74 (04) : 433 - 436
  • [47] A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer
    Sehouli, Jalid
    Camara, Oumar
    Mahner, Sven
    Bauknecht, Thomas
    Lichtenegger, Werner
    Runnebaum, Ingo
    Look, Katherine
    Jaenicke, Fritz
    Oskay-Oezcelik, Guelten
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (05) : 861 - 868
  • [48] A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer
    Jalid Sehouli
    Oumar Camara
    Sven Mahner
    Thomas Bauknecht
    Werner Lichtenegger
    Ingo Runnebaum
    Katherine Look
    Fritz Jaenicke
    Guelten Oskay-Oezcelik
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 861 - 868
  • [49] Tislelizumab plus cisplatin/carboplatin and gemcitabine versus placebo plus cisplatin/carboplatin and gemcitabine in Chinese patients with advanced urothelial carcinoma: A phase III trial in progress
    Bi, Feng
    Li, Han-Zhong
    Zhu, Shaoxing
    Zou, Qing
    Tang, Jia
    Zhang, Wei
    Ye, Dingwei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [50] Combination chemotherapy with taxane and platinum in patients with salivary gland carcinoma: a retrospective study of docetaxel plus cisplatin and paclitaxel plus carboplatin
    Onaga, Ryutaro
    Enokida, Tomohiro
    Ito, Kazue
    Ueda, Yuri
    Okano, Susumu
    Fujisawa, Takao
    Wada, Akihisa
    Sato, Masanobu
    Tanaka, Hideki
    Takeshita, Naohiro
    Tanaka, Nobukazu
    Hoshi, Yuta
    Tahara, Makoto
    FRONTIERS IN ONCOLOGY, 2023, 13
12345